• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Mar 15, 1998; 101(6): 1362–1372.
PMCID: PMC508691

Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes.


One of the hallmarks of SLE is the loss of tolerance to chromatin. The genes and mechanisms that trigger this loss of tolerance remain unknown. Our genetic studies in the NZM2410 lupus strain have implicated genomic intervals on chromosomes 1 (Sle1), 4 (Sle2), and 7 (Sle3) as conferring strong lupus susceptibility. Interestingly, B6 mice that are congenic for Sle1 (B6.NZMc1) have elevated IgG antichromatin Abs. This study explores the antinuclear antibody fine specificities and underlying cellular defects in these mice. On the B6 background, Sle1 by itself is sufficient to generate a robust, spontaneous antichromatin Ab response, staining Hep-2 nuclei homogeneously, and reacting primarily with H2A/H2B/DNA subnucleosomes. This targeted immune response peaks at 7-9 mo of age, affects both sexes with equally high penetrance (> 75%), and interestingly, does not "spread" to other subnucleosomal chromatin components. Sle1 also leads to an expanded pool of histone-reactive T cells, which may have a role in driving the anti-H2A/H2B/DNA B cells. However, these mice do not exhibit any generalized immunological defects or quantitative aberrations in lymphocyte apoptosis. We hypothesize that Sle1 may lead to the presentation of chromatin in an immunogenic fashion, or directly impact tolerance of chromatin-specific B cells.

Full Text

The Full Text of this article is available as a PDF (490K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mohan C, Datta SK. Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol. 1995 Dec;77(3):209–220. [PubMed]
  • Theofilopoulos AN. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol Today. 1995 Feb;16(2):90–98. [PubMed]
  • HOLMAN HR, DEICHER HR, KUNKEL HG. The L. E. cell and the L. E. serum factors. Bull N Y Acad Med. 1959 Jul;35(7):409–418. [PMC free article] [PubMed]
  • Stollar BD. Reactions of systemic lupus erythematosus sera with histone fractions and histone-DNA complexes. Arthritis Rheum. 1971 Jul-Aug;14(4):485–492. [PubMed]
  • Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest. 1994 Jul;94(1):184–192. [PMC free article] [PubMed]
  • Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest. 1993 Apr;91(4):1687–1696. [PMC free article] [PubMed]
  • Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993 May 1;177(5):1367–1381. [PMC free article] [PubMed]
  • Kaliyaperumal A, Mohan C, Wu W, Datta SK. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med. 1996 Jun 1;183(6):2459–2469. [PMC free article] [PubMed]
  • Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest. 1995 Feb;95(2):531–541. [PMC free article] [PubMed]
  • Filaci G, Grasso I, Contini P, Imro MA, Lanza L, Scudeletti M, Rossi E, Puppo F, Damasio E, Indiveri F. dsDNA-, nucleohistone- and DNASE I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: correlation with clinical disease activity. Clin Exp Rheumatol. 1996 Sep-Oct;14(5):543–550. [PubMed]
  • Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 1996 May 3;85(3):311–318. [PubMed]
  • Kono DH, Theofilopoulos AN. Genetic contributions to SLE. J Autoimmun. 1996 Aug;9(4):437–452. [PubMed]
  • Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity. 1994 Jun;1(3):219–229. [PubMed]
  • Morel L, Yu Y, Blenman KR, Caldwell RA, Wakeland EK. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome. 1996 May;7(5):335–339. [PubMed]
  • Morel L, Mohan C, Yu Y, Croker BP, Tian N, Deng A, Wakeland EK. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol. 1997 Jun 15;158(12):6019–6028. [PubMed]
  • Mohan TC, Nadarajah M, Sng EH. Relation of antinuclear fluorescence patterns and titres to autoantibody prevalence. Ann Acad Med Singapore. 1989 Jul;18(4):339–344. [PubMed]
  • Mohan C, Shi Y, Laman JD, Datta SK. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol. 1995 Feb 1;154(3):1470–1480. [PubMed]
  • Burlingame RW, Rubin RL. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods. 1990 Dec 5;134(2):187–199. [PubMed]
  • Losman MJ, Fasy TM, Novick KE, Monestier M. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. J Immunol. 1992 Mar 1;148(5):1561–1569. [PubMed]
  • Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991 Jun 3;139(2):271–279. [PubMed]
  • Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach JF, Jacob L. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 1994 Nov;37(11):1684–1688. [PubMed]
  • Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest. 1993 Apr;68(4):419–426. [PubMed]
  • HARGRAVES MM, RICHMOND H, MORTON R. Presentation of two bone marrow elements; the tart cell and the L.E. cell. Proc Staff Meet Mayo Clin. 1948 Jan 21;23(2):25–28. [PubMed]
  • HOLMAN HR, KUNKEL HG. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science. 1957 Jul 26;126(3265):162–163. [PubMed]
  • HOLMAN H, DEICHER HR. The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus. J Clin Invest. 1959 Nov;38:2059–2072. [PMC free article] [PubMed]
  • Agnello V, Arbetter A, Ibanez de Kasep G, Powell R, Tan EM, Joslin F. Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med. 1980 Jun 1;151(6):1514–1527. [PMC free article] [PubMed]
  • Rekvig OP, Hannestad K. Human autoantibodies that react with both cell nuclei and plasma membranes display specificity for the octamer of histones H2A, H2B, H3, and H4 in high salt. J Exp Med. 1980 Dec 1;152(6):1720–1733. [PMC free article] [PubMed]
  • Chabre H, Amoura Z, Piette JC, Godeau P, Bach JF, Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 1995 Oct;38(10):1485–1491. [PubMed]
  • Reeves WH, Satoh M, Wang J, Chou CH, Ajmani AK. Systemic lupus erythematosus. Antibodies to DNA, DNA-binding proteins, and histones. Rheum Dis Clin North Am. 1994 Feb;20(1):1–28. [PubMed]
  • McGhee JD, Felsenfeld G. Nucleosome structure. Annu Rev Biochem. 1980;49:1115–1156. [PubMed]
  • Nelson DA, Mencke AJ, Chambers SA, Oosterhof DK, Rill RL. Subnucleosomes and their relationships to the arrangement of histone binding sites along nucleosome deoxyribonucleic acid. Biochemistry. 1982 Aug 31;21(18):4350–4362. [PubMed]
  • Oohara I, Wada A. Spectroscopic studies on histone-DNA interactions. I. The interaction of histone (H2A, H2B) dimer with DNA: DNA sequence dependence. J Mol Biol. 1987 Jul 20;196(2):389–397. [PubMed]
  • Tatchell K, Van Holde KE. Reconstitution of chromatin core particles. Biochemistry. 1977 Nov 29;16(24):5295–5303. [PubMed]
  • Beaudette NV, Fulmer AW, Okabayashi H, Fasman GD. Study of conformational states and reversibility of histone complexes. Biochemistry. 1981 Nov 10;20(23):6526–6535. [PubMed]
  • LACHMANN PJ, KUNKEL HG. Correlation of antinuclear antibodies and nuclear staining patterns. Lancet. 1961 Aug 19;2(7199):436–437. [PubMed]
  • Tan EM. Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. J Lab Clin Med. 1967 Nov;70(5):800–812. [PubMed]
  • Arents G, Burlingame RW, Wang BC, Love WE, Moudrianakis EN. The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10148–10152. [PMC free article] [PubMed]
  • Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 1996 Jun;39(6):894–903. [PubMed]
  • Bernstein KA, Valerio RD, Lefkowith JB. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol. 1995 Mar 1;154(5):2424–2433. [PubMed]
  • Kramers C, Hylkema MN, van Bruggen MC, van de Lagemaat R, Dijkman HB, Assmann KJ, Smeenk RJ, Berden JH. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest. 1994 Aug;94(2):568–577. [PMC free article] [PubMed]
  • Rubin RL, Bell SA, Burlingame RW. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest. 1992 Jul;90(1):165–173. [PMC free article] [PubMed]
  • Rubin RL, McNally EM, Nusinow SR, Robinson CA, Tan EM. IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupus. Clin Immunol Immunopathol. 1985 Jul;36(1):49–59. [PubMed]
  • Totoritis MC, Tan EM, McNally EM, Rubin RL. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Engl J Med. 1988 Jun 2;318(22):1431–1436. [PubMed]
  • Fisher CL, Shores EW, Eisenberg RA, Cohen PL. Cellular interactions for the in vitro production of anti-chromatin autoantibodies in MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol. 1989 Feb;50(2):231–240. [PubMed]
  • Mohan C, Morel L, Yang P, Wakeland EK. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol. 1997 Jul 1;159(1):454–465. [PubMed]
  • Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol. 1994 Apr 1;152(7):3685–3692. [PubMed]
  • Van Houten N, Budd RC. Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J Immunol. 1992 Oct 1;149(7):2513–2517. [PubMed]
  • Reap EA, Leslie D, Abrahams M, Eisenberg RA, Cohen PL. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J Immunol. 1995 Jan 15;154(2):936–943. [PubMed]
  • Kozono Y, Kotzin BL, Holers VM. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J Immunol. 1996 Jun 1;156(11):4498–4503. [PubMed]
  • Lambert PH, Dixon FJ. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med. 1968 Mar 1;127(3):507–522. [PMC free article] [PubMed]
  • Raptis L, Menard HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest. 1980 Dec;66(6):1391–1399. [PMC free article] [PubMed]
  • McCoubrey-Hoyer A, Okarma TB, Holman HR. Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am J Med. 1984 Jul;77(1):23–34. [PubMed]
  • Steinman CR. Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J Clin Invest. 1984 Mar;73(3):832–841. [PMC free article] [PubMed]
  • Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994 Apr 1;179(4):1317–1330. [PMC free article] [PubMed]
  • Sobel ES, Katagiri T, Katagiri K, Morris SC, Cohen PL, Eisenberg RA. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J Exp Med. 1991 Jun 1;173(6):1441–1449. [PMC free article] [PubMed]
  • Roark JH, Kuntz CL, Nguyen KA, Caton AJ, Erikson J. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J Exp Med. 1995 Mar 1;181(3):1157–1167. [PMC free article] [PubMed]
  • Reininger L, Winkler TH, Kalberer CP, Jourdan M, Melchers F, Rolink AG. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice. J Exp Med. 1996 Sep 1;184(3):853–861. [PMC free article] [PubMed]
  • Tsao BP, Cantor RM, Kalunian KC, Chen CJ, Badsha H, Singh R, Wallace DJ, Kitridou RC, Chen SL, Shen N, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest. 1997 Feb 15;99(4):725–731. [PMC free article] [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • Gene
    Gene links
  • MedGen
    Related information in MedGen
  • OMIM
    OMIM record citing PubMed
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...